Results 51 to 60 of about 219,523 (189)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders [PDF]

open access: yesHospital Pharmacology, 2019
Introduction: Although before, the prioritization of positive and negative symptoms of schizophrenia over neurocognitive impairment was of the highest importance, recent scientific achievements suggest that the disrupted neurocognitive functions are the ...
Javorac Jovan M.   +4 more
doaj  

Comparison of short term effects of risperidone and paliperidone on serum prolactin levels in female patients

open access: yesPsychiatry and Behavioral Sciences, 2014
Objective: Hyperprolactinemia is an adverse effect, which is related with the use of antipsychotics. All typical antipsychotics are considered to increase serum prolactin levels.
Yakup Albayrak   +3 more
doaj   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka   +6 more
wiley   +1 more source

Sleep Disorders in Klinefelter Syndrome and Other Sex Chromosome Aneuploidies: A Narrative Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Sex chromosome aneuploidies (SCAs) are among the most frequent types of chromosomal aneuploidies and include Klinefelter syndrome (47,XXY and higher‐grade variants), 47,XYY syndrome, Turner syndrome (45,X), and trisomy X (47,XXX).
Roberto Paparella   +3 more
wiley   +1 more source

Reply: Atypical Antipsychotics and Neuroleptic Malignant Syndrome

open access: yes, 2001
The epidemiology of Neuroleptic Malignant Syndrome (NMS) has been only recently examine das far as atypical antipsychotics are concerned. Further research is necessary regarding this clinical area, but preliminary data confim the risk of NMS by using ...
BIANCOSINO, Bruno   +3 more
core   +1 more source

Voice Fundamental Frequency Variation and Statin Therapy

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objectives Statins are considered a first‐line treatment for dyslipidaemia, being the most frequently prescribed medicine worldwide. However, statin therapy has been associated with several adverse effects, including statin‐associated myopathy, which may manifest with symptoms such as myalgia, muscle stiffness, and cramps.
Luca Francesco Parata   +5 more
wiley   +1 more source

Lista incluidos-Side effects of atypical antipsychotics. A systematic review

open access: yes, 2023
Atypical antipsychotics, also known as second-generation antipsychotics, have demonstrated efficacy in controlling both positive and negative symptoms of schizophrenia, as well as in the treatment of other psychotic disorders.
Danny Raúl Zúñiga Carrasco (14302370)   +6 more
core   +1 more source

Severe tardive dystonia on low dose short duration exposure to atypical antipsychotics: Factors explored

open access: yesIndian Journal of Psychological Medicine, 2017
Tardive dystonia (TD) is a serious side effect of antipsychotic medications, more with typical antipsychotics, that is potentially irreversible in affected patients. Studies show that newer atypical antipsychotics have a lower risk of TD.
Nilanjan C Chandra   +3 more
doaj   +1 more source

Typical and Atypical Antipsychotic Drug Utilization in a Psychiatric Clinic in Palestine [PDF]

open access: yesمجلة جامعة النجاح للأبحاث العلوم الطبيعية, 2004
Pattern of atypical and typical antipsychotic medications among one hundred and twenty four patients receiving these medications was investigated and analyzed. Males constitute approximately 61% of the sample. More than half of the patients in the sample
Nidal Jaradat, Abed Alsalam Al-Khayyat
doaj   +1 more source

Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma‐1 Receptor Modulation

open access: yesThe FEBS Journal, EarlyView.
We investigated the potential of iloperidone as an activator of Sigma‐1 receptor (S1R) neuroprotective function in juvenile Huntington's disease (jHD). We tested iloperidone on cortical neurons differentiated from patient‐derived iPSCs, demonstrating that it acts as a S1R agonist, decreasing apoptosis, huntingtin aggregation, and oxidative stress ...
Ersilia Fornetti   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy